| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 26, 2021 | Oct 26, 2021 | Xilio Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +500,000 | 66.10% | ✗ | $8M |
| Nov 3, 2020 | Nov 4, 2020 | Atea Pharmaceuticals, Inc. | 10% Owner | Buy | 100.0 | +250,000 | 14.75% | ✗ | $6M |
| Mar 16, 2020 | Mar 16, 2020 | Enliven Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +250,000 | 91.44% | ✗ | $4M |
| Apr 2, 2018 | Apr 4, 2018 | Q32 Bio Inc. | 10% Owner | Buy | 100.0 | +250,000 | 63.16% | ✗ | $4M |